OPACT® Starch Lactose

OPACT® Starch Lactose is a co‑processed direct compression excipient manufactured by spray‑drying a composite of approximately 85% α‑lactose monohydrate and 15% maize starch. It is specifically designed for tablet and capsule formulation, providing excellent flowability, superior compressibility, and rapid disintegration independent of tablet hardness.

  • Item No :

    OPACT® Starch Lactose
  • Product Origin :

    CHINA
  • Shipping Port :

    SHANG HAI
  • Payment :

    TT/LC
  • Weight :

    20/25KG
  • Order(MOQ) :

    100KG

Product Introduction

 

OPACT® Starch Lactose is a high‑performance pharmaceutical excipient developed through a proprietary spray‑drying process that intimately combines α‑lactose monohydrate with maize starch. This co‑processing creates a synergistic structure that delivers outstanding powder flow, remarkable compressibility, and fast, hardness‑independent disintegration. The material exhibits both brittle and plastic deformation characteristics, making it highly versatile across multiple tablet manufacturing processes. Its hydrophilic nature enhances the dissolution and release profile of active pharmaceutical ingredients, while its resistance to over‑lubrication ensures consistent tablet quality even under varying lubricant conditions.

 

 

Product Feature

 

  • Excellent Flowability
  • Superior Compressibility
  • Rapid Disintegration Independent of Tablet Hardness
  • Anti Over‑Lubrication Sensitivity
  • Enhanced Hydrophilicity for Improved API Dissolution
  • Dual Deformation Behavior – Suitable for Dry Granulation
  • Low Moisture Absorption at Ambient Humidity
  • Consistent Particle Size Distribution

 

 

Product Application

 

OPACT® Starch Lactose is primarily engineered for orally disintegrating tablets (ODT) and dispersible tablets, where its rapid, hardness‑independent disintegration delivers a pleasant patient experience with disintegration times consistently below 3 minutes even at elevated tablet hardness. Its exceptional compressibility and free‑flowing nature make it an ideal filler‑binder for direct compression tablets across a wide range of therapeutic categories, including cardiovascular, respiratory, gastrointestinal, and endocrine medications. For formulations requiring dry granulation, the material's combined brittle and plastic deformation properties ensure robust ribbon formation and subsequent tablet strength. Beyond conventional pharmaceuticals, OPACT® Starch Lactose is equally well suited for hard capsule filling, chewable tablets, and compressed nutraceutical products such as dietary supplements and pressed candies, offering formulators a single, multifunctional excipient that simplifies composition and streamlines production.

 

 

Product Specification

 

Composition Loss on Drying (%) Bulk Density (g/ml)

~85% α‑Lactose Monohydrate;

~15% Maize Starch

≤ 4.0 0.45-0.65

 

 

Packaging

 

  • 20-foot container can hold 10 to 11 metric tons of OPACT® Starch Lactose.
  • Standard packaging of 20/25 kg per bag.

 

 

Hot Tags :
leave a message
If you are interested in our products and want to know more details,please leave a message here,we will reply you as soon as we can.

Related Products

OPACT® SMCC 50
OPACT® SMCC 50

OPACT® SMCC 50 is a silicified microcrystalline cellulose excipient made of 98% MCC and 2% colloidal silicon dioxide by co-processing. It delivers excellent compressibility and good flowability for direct compression and dry granulation in oral solid dosage forms.

Read More
OPACT® SMCC 90
OPACT® SMCC 90

OPACT® SMCC 90 is a silicified microcrystalline cellulose excipient combining 98% MCC with 2% colloidal silicon dioxide. It offers the optimal balance of flowability and compressibility for direct compression and dry granulation in oral solid dosage forms.

Read More
OPACT® DMCC 25
OPACT® DMCC 25

OPACT® DMCC 25 is a co-processed excipient composed of mannitol, microcrystalline cellulose, and silicon dioxide. Designed for pharmaceutical and health food applications, it is specifically engineered to support the formulation and production of orally disintegrating tablets.

Read More
OPACT® DMCC 30
OPACT® DMCC 30

OPACT® DMCC 30 is a novel co-processed pharmaceutical excipient composed of mannitol, microcrystalline cellulose, crospovidone, and colloidal silicon dioxide. It is specifically engineered for oral fast-disintegrating tablets, ensuring rapid disintegration and a pleasant mouthfeel.

Read More
OPACT® MCPP
OPACT® MCPP

OPACT® MCPP​ is Westpoint's co-processed direct compression premix composed of D-mannitol, crospovidone, polyvinyl acetate, and povidone. Engineered for orally disintegrating tablets (ODTs), it combines filling, binding, and disintegrating functions in one free-flowing powder — enabling simple blending with APIs and lubricants for direct tableting.

Read More
OPACT® LMCC
OPACT® LMCC

OPACT® LMCC is a co-processed pharmaceutical excipient composed of 75% alpha-lactose monohydrate and 25% microcrystalline cellulose, specifically designed for direct compression as a high-performance filler and binder in tablets, capsules, and granules.

Read More
OPACT® LPCC
OPACT® LPCC

OPACT® LPCC is a co-processed pharmaceutical excipient combining lactose and powdered cellulose. It offers excellent compressibility, flowability, and disintegration, serving as a versatile multifunctional filler and binder for solid dosage formulations.

Read More
OPACT® LPC
OPACT® LPC

OPACT® LPC is a co-processed pharmaceutical excipient combining lactose monohydrate, povidone, and crospovidone into a single free-flowing premix. Engineered for direct compression and hard capsule filling, it integrates filler, binder, and disintegrant functions in one standardized system, helping pharmaceutical manufacturers streamline formulation and accelerate tablet production.

Read More